SOLDUXTRIPriority claimed from 06/07/2017; Application No. : 87517393 ;United States of America (Class 5)
#3706256
Application Number:3706256
Status:
DRAFT
Class:5
Applicant: JOHNSON & JOHNSON
Filing Date:Tue, 19 Dec 2017
Get a free email alert the moment this application's status changes.
Trademark Information
| Trademark | SOLDUXTRIPriority claimed from 06/07/2017; Application No. : 87517393 ;United States of America |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 3706256 |
| Nature/Scope of business | Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; vaccines. |
| Publication | In Journal No. 1944 |
| Status | DRAFT |
| Applicant: | JOHNSON & JOHNSON |
| Applicant Address | ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK, NEW JERSEY, 08933, U.S.A. A corporation organized and existing under the laws of the State of New Jersey, U.S.A. |
| Jurisdiction | DELHI |
| Agent | LALL & SETHI |
| Agent Address | D - 17, SOUTH EXTENSION PART - II, NEW DELHI - 110 049. |
Frequently Asked Questions
What is the status of trademark SOLDUXTRIPriority claimed from 06/07/2017; Application No. : 87517393 ;United States of America? ▾
The trademark application number 3706256 is currently marked as "DRAFT" in the official trademark registry.
Who is the owner of trademark SOLDUXTRIPriority claimed from 06/07/2017; Application No. : 87517393 ;United States of America? ▾
The trademark application number 3706256 is owned by JOHNSON & JOHNSON.
Which class does trademark SOLDUXTRIPriority claimed from 06/07/2017; Application No. : 87517393 ;United States of America belong to? ▾
Trademark application number 3706256 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 3706256? ▾
The trademark agent associated with application number 3706256 is LALL & SETHI.
Was trademark SOLDUXTRIPriority claimed from 06/07/2017; Application No. : 87517393 ;United States of America published in the journal? ▾
Yes, trademark application number 3706256 was published in Journal No. 1944.
What is trademark SOLDUXTRIPriority claimed from 06/07/2017; Application No. : 87517393 ;United States of America? ▾
Trademark application number 3706256 relates to "Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; vaccines.".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified